Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Oxybate vs Zolpidem in Chronic Insomnia
NCT00383643Phase 2Completed
- Sponsor
- Stanford University
- Start
- May 2006
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sodium oxybate in Insomnia (3 arms), sponsored by Stanford University. Primary endpoints: Clinical Global Impression - Change at 12 weeks, Insomnia Severity Index at 12 weeks and 3 more. Started May 2006; status: completed.
02
Drugs
sodium oxybate
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00383643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00383643.